Products for Research Use Only

Recombinant human KRT17 protein

CAT: 0112-ATGP2580-100Size: 100 µgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0112-ATGP2580-100Size:100 µg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
KRT17, as known as keratin17, is a type I cytokeratin. It is found in nail beds, hair follicles, sebaceous glands, and other epidermal appendages. Mutations in KRT17 lead to Jackson-Lawler type pachyonychia congenita and steatocystoma multiplex. Recombinant human KRT17 protein, fused to His-tag at N-terminus, was expressed in E. coli.
Product Name Alternative
Keratin type I cytoskeletal 17, Keratin, type I cytoskeletal 17, K17, PC, PC2, PCHC1
Expression System
E.coli
Antigen Species
Human
Tag
His-Tag
Applications
SDS-PAGE, Denatured
Concentration
0.5 mg/mL (determined by Bradford assay)
Purity
> 90% by SDS-PAGE
Molecular Weight
50.5 kDa (455aa)
Additionnal Information
KRT17, Keratin type I cytoskeletal 17, Keratin, type I cytoskeletal 17, K17, PC, PC2, PCHC1, ATGP2580-10 µg, ATGP2580-20 µg, ATGP2580-50 µg, ATGP2580-100 µg, ATGP2580-250 µg, ATGP2580-500 µg, ATGP2580-1 mg, ATGP2580-10, ATGP2580-20, ATGP2580-50, ATGP2580-100, ATGP2580-250, ATGP2580-500, ATGP2580-1
References & Citations
McLean WH. et al. (1995) Nat Genet. 9:273-278.; ; Troyanovsky SM. et al. (1993) Eur J Cell Biol. 59: 127-137.;
Storage Conditions
Can be stored at 2°C to 8°C for 1 week. For long term storage, aliquot and store at -20C to -80C. Avoid repeated freezing and thawing cycles.
Formulation
Liquid in. 20 mM Tris-HCl buffer (pH 8.0) containing 10% glycerol 0.4M urea
Scientific Category
Signal Transduction
NCBI Accession Number
NP_000413
Uniprot Accession Number
Q04695
Species
Human
AA Sequence
MGSSHHHHHH SSGLVPRGSH MGSMTTSIRQ FTSSSSIKGS SGLGGGSSRT SCRLSGGLGA GSCRLGSAGG LGSTLGGSSY SSCYSFGSGG GYGSSFGGVD GLLAGGEKAT MQNLNDRLAS YLDKVRALEE ANTELEVKIR DWYQRQAPGP ARDYSQYYRT IEELQNKILT ATVDNANILL QIDNARLAAD DFRTKFETEQ ALRLSVEADI NGLRRVLDEL TLARADLEMQ IENLKEELAY LKKNHEEEMN ALRGQVGGEI NVEMDAAPGV DLSRILNEMR DQYEKMAEKN RKDAEDWFFS KTEELNREVA TNSELVQSGK SEISELRRTM QALEIELQSQ LSMKASLEGN LAETENRYCV QLSQIQGLIG SVEEQLAQLR CEMEQQNQEY KILLDVKTRL EQEIATYRRL LEGEDAHLTQ YKKEPVTTRQ VRTIVEEVQD GKVISSREQV HQTTR